Park YS - Search Results

1

Comparison of Antitumor Effects of Combinations of Immune Checkpoint Inhibitors With Dendritic Cells Intratumorally Injected into Irradiated Mouse Adenocarcinoma.

Park GY, Son WC, Lee HR, Koh EK, Kang HB, Song JH, Kim DW, Kim Y, Park YS. Park GY, et al. Among authors: park ys. J Immunother. 2024 Dec 27. doi: 10.1097/CJI.0000000000000548. Online ahead of print. J Immunother. 2024. PMID: 39726268

2

CTLA-4 blockade enhances antitumor immunity of intratumoral injection of immature dendritic cells into irradiated tumor in a mouse colon cancer model.

Son CH, Bae JH, Shin DY, Lee HR, Choi YJ, Jo WS, Ho Jung M, Kang CD, Yang K, Park YS. Son CH, et al. Among authors: park ys. J Immunother. 2014 Jan;37(1):1-7. doi: 10.1097/CJI.0000000000000007. J Immunother. 2014. PMID: 24316550

3

Enhanced dendritic cell-based immunotherapy using low-dose cyclophosphamide and CD25-targeted antibody for transplanted Lewis lung carcinoma cells.

Son CH, Bae JH, Lee HR, Shin DY, Yang K, Park YS. Son CH, et al. Among authors: park ys. J Immunother. 2015 Apr;38(3):107-15. doi: 10.1097/CJI.0000000000000068. J Immunother. 2015. PMID: 25751500

4

Combination treatment with decitabine and ionizing radiation enhances tumor cells susceptibility of T cells.

Son CH, Lee HR, Koh EK, Shin DY, Bae JH, Yang K, Park YS. Son CH, et al. Among authors: park ys. Sci Rep. 2016 Sep 27;6:32470. doi: 10.1038/srep32470. Sci Rep. 2016. PMID: 27671170 Free PMC article.

5

Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody.

Lee HR, Son CH, Koh EK, Bae JH, Kang CD, Yang K, Park YS. Lee HR, et al. Among authors: park ys. Sci Rep. 2017 Sep 11;7(1):11075. doi: 10.1038/s41598-017-09259-1. Sci Rep. 2017. PMID: 28894091 Free PMC article.

6

Combination Treatment of Stereotactic Body Radiation Therapy and Immature Dendritic Cell Vaccination for Augmentation of Local and Systemic Effects.

Choi CW, Jeong MH, Park YS, Son CH, Lee HR, Koh EK. Choi CW, et al. Among authors: park ys. Cancer Res Treat. 2019 Apr;51(2):464-473. doi: 10.4143/crt.2018.186. Epub 2018 Jun 6. Cancer Res Treat. 2019. PMID: 29879758 Free PMC article.

7

Antitumor effects of NK cells expanded by activation pre‑processing of autologous feeder cells before irradiation in colorectal cancer.

Koh EK, Lee HR, Son WC, Park GY, Bae J, Park YS. Koh EK, et al. Among authors: park ys, park gy. Oncol Lett. 2023 Apr 18;25(6):232. doi: 10.3892/ol.2023.13818. eCollection 2023 Jun. Oncol Lett. 2023. PMID: 37153058 Free PMC article.

8

Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer.

Koh EK, Lee HR, Son WC, Park GY, Kim J, Bae JH, Park YS. Koh EK, et al. Among authors: park ys, park gy. Sci Rep. 2023 May 11;13(1):7656. doi: 10.1038/s41598-023-34827-z. Sci Rep. 2023. PMID: 37169953 Free PMC article.

9

Combination Effect of Radiotherapy and Targeted Therapy with NK Cell-Based Immunotherapy in head and Neck Squamous Cell Carcinoma.

Son WC, Lee HR, Koh EK, Park GY, Kang HB, Song J, Ahn SY, Park YS. Son WC, et al. Among authors: park ys, park gy. Immunol Invest. 2024 Nov 19:1-17. doi: 10.1080/08820139.2024.2428199. Online ahead of print. Immunol Invest. 2024. PMID: 39560204

10

An inhibitor of programmed death ligand 1 enhances natural killer cell-mediated immunity against malignant melanoma cells.

Lee YS, Heo W, Choi HJ, Cho HR, Nam JH, Ki YG, Lee HR, Son WC, Park YS, Kang CD, Bae J. Lee YS, et al. Among authors: park ys. PLoS One. 2021 Apr 1;16(4):e0248870. doi: 10.1371/journal.pone.0248870. eCollection 2021. PLoS One. 2021. PMID: 33793576 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,239 results

Search Page

Filters